Europe

Showing 15 posts of 198 posts found.

WHO: New measures needed to reduce high drug costs

March 26, 2015
Research and Development, Sales and Marketing Europe, WHO, pricing, transparency, world health organization

New approaches to drug pricing and reimbursement are needed to make sure pharma provides access to new medicines, according to …

Chiesi image

Chiesi’s stem cell therapy approved in Europe

February 23, 2015
Research and Development, Sales and Marketing Chiesi, EC, Europe, Holoclar, Holostem Advanced Therapies, LSCD, stem cell

Chiesi’s Holoclar has become the first stem cell therapy to get the green light in Europe, gaining conditional approval from …

EMA image

EMA launches consultation on clinical trials

January 22, 2015
Research and Development, Sales and Marketing EFPIA, EMA, EU, Europe, Goldacre, alltrials, transparency

The European Medicines Agency has invited pharma to comment on its proposals to ramp up transparency in the industry and …

Cyramza

Lilly to market stomach cancer drug in Europe

December 22, 2014
Sales and Marketing Eli Lilly, Europe, FDA, US, cyramza, ramucirumab, stomach cancer

Eli Lilly has been granted permission by the European Commission to market Cyramza in Europe. Lilly’s Cyramza (ramucirumab) is the …

GSK image

GSK Ebola vaccine gets EU support

December 17, 2014
Research and Development, Sales and Marketing EC, EU, Ebola, Europe, GSK, Merck, Takeda, Vaccine, WHO, johnson

A newly-formed European consortium is to help advance the development of GlaxoSmithKline’s promising Ebola vaccine. The consortium is backed by …

BI image

Boehringer’s lung cancer drug Vargatef sees EU approval

November 28, 2014
Sales and Marketing Boehringer, EU, Europe, IPF, NSCLC, lung cancer, nintedanib, ofev, vargatef

Boehringer Ingelheim’s nintedanib has received its second nod in Europe this month with the European Commission approving it for the …

Advair image

Europe must prepare for COPD ‘timebomb’

November 19, 2014
Sales and Marketing COPD, Europe, European COPD Coalition, Spiriva, asthma, chronic obstructive pulmonary disease

Health services in Europe are not making sufficient effort to cope with the escalating burden of chronic obstructive pulmonary disease …

Rasi image

EMA in turmoil as top job ‘annulled’

November 17, 2014
Sales and Marketing EC, EMA, EU, Europe, Guido Rasi, Rasi, transparency

The future of Guido Rasi, head of Europe’s drugs regulator, is up in the air after a legal ruling which …

Telemedicine image

Telemedicine EU market ‘expected to triple’ by 2020

July 8, 2014
Medical Communications, Sales and Marketing Europe, Frost & Sullivan, analysts, telemedicine

The telemedicine market in Europe is poised for rapid growth and can help keep overall healthcare costs down, according to …

janssen image

Janssen abandons Simponi application

May 23, 2014
Sales and Marketing Europe, Janssen, RA, Simponi, rheumatoid arthritis

Janssen Biologics has withdrawn its application to add an intravenous (IV) form to the marketing authorisation of veteran rheumatoid arthritis …

Ema image

EMA to conduct major review into testosterone drugs

April 14, 2014
Research and Development, Sales and Marketing EMA, EU, Europe, heart, testosterone

The European Medicines Agency has started a review of testosterone-containing medicines as concerns grow that they may increase the risk …

ema_building_face_web

EMA transparency agenda sees more delay

April 9, 2014
Medical Communications, Sales and Marketing AbbVie, EFPIA, EMA, Europe, InterMune, alltrials, parliament, transparency

The European Medicines Agency is to further delay its policy over clinical trial transparency, saying it needs more time to …

votrient image

Votrient’s extended licence application ditched

April 1, 2014
Sales and Marketing EMA, Europe, GSK, ovarian, votrient kidney cancer

GlaxoSmithKline admits it is ‘disappointed’ after abandoning its attempt to extend kidney cancer drug Votrient’s licence to take in ovarian …

Europe to vote on greater trial transparency

December 17, 2013
Research and Development, Sales and Marketing EU, Europe, Goldacre, alltrials, transparency

Pharma companies and academic researchers will be obliged to upload the results of all their European clinical trials to a …

Billions spent on European cancer care

October 15, 2013
Research and Development, Sales and Marketing Cancer, Europe, Lancet, Oxford, Pfizer

A new report has shown that cancer cost the European Union a total of €126 billion in 2009, with healthcare …

The Gateway to Local Adoption Series

Latest content